Trials / Terminated
TerminatedNCT03325296
Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata.
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial attempts to investigate the efficacy of LEO 124249 ointment in the treatment of alopecia areata on the eyebrows.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LEO 124249 | Ointment containing LEO 124249 |
| OTHER | Ointment vehicle | Ointment without active ingredients |
Timeline
- Start date
- 2017-10-30
- Primary completion
- 2018-05-16
- Completion
- 2018-05-16
- First posted
- 2017-10-30
- Last updated
- 2025-02-24
Locations
2 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03325296. Inclusion in this directory is not an endorsement.